Promega launches new Lumit assays

By Leah Sherwood, The Science Advisory Board assistant editor

March 31, 2022 -- Life sciences firm Promega has launched new bioluminescent assays for researchers studying immunity and inflammation.

Lumit Cytokine Immunoassays can now quantitatively detect cytokine release from cell culture samples in 70 minutes compared to hours via traditional assays, the company said.

The immunoassays were designed to aid in basic research or high-throughput screening for drug discovery and development. The company said that while traditional enzyme-linked immunosorbent assays-based cytokine detection methods can require hours of hands-on time to produce results, Lumit Cytokine Immunoassays offer a simpler, faster protocol.


Copyright © 2022 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.